Tempus AI price target raised to $60 from $54 at BofA
BofA raised the firm’s price target on Tempus AI (TEM) to $60 from $54 and keeps a Neutral rating on the shares after the company reported Q4 ...
Bank of America Securities Keeps Their Hold Rating on Tempus AI, Inc. Class A (TEM)
In a report released today, Michael Ryskin from Bank of America Securities maintained a Hold rating on Tempus AI, Inc. Class A (TEM – Research ...
Barchart on MSN1h
Cathie Wood Loves This Under-the-Radar AI Stock. Is It Time for You to Buy Now?
Although buying the dip is never a sure bet, iconic investor Cathie Wood believes loading up on shares of beaten-down Tempus AI (TEM) now is a great move. Yet to be profitable, Tempus has notable ...
These are the top 10 February stock purchases on Robinhood UK
UK remained focused on artificial intelligence (AI) and cryptocurrency in February, despite market volatility, according to the platform’s latest trading data.
Investor's Business Daily on MSN4h
AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.
AbbVie inked a licensing deal Monday worth up to $2.23 billion for an amylin-targeting obesity treatment from Denmark-based ...